WebbTraining for global care: Ophthalmology resident sets up two eye care programs in the Middle East; Mentorship leads to new gene therapy discoveries; 3D bioprinting to eliminate corneal blindness; Big data to transform patient care; Inventing a new outlook: Restoring sight with electronic photoreceptors and augmented reality glasses WebbLight therapy for dry age-related macular degeneration. Diana Do, MD, professor of ophthalmology, has over 17 years of experience leading clinical trials geared towards developing cutting-edge treatment for retinal diseases. Recently, Do has devoted a significant portion of her research effort to developing more effective treatments for AMD.
Nanoscope Therapeutics to Present at the Retina Forum 2024
Webb1 okt. 2024 · CHICAGO, Oct. 1, 2024 - The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the primary results from the Phase 1/2 study … Webb1 okt. 2024 · CHICAGO, Oct. 1, 2024 - The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the primary results from the Phase 1/2 study evaluating the investigational gene therapy botaretigene sparoparvovec (formerly AAV-RPGR) in patients with the inherited retinal disease X-linked retinitis pigmentosa … 駿河屋 ウォーハンマー
Looking to the Future of Gene Therapy in Ophthalmology
Webb“While lowering intraocular pressure is the standard treatment for glaucoma, there are no therapies that directly treat the optic nerve neurodegeneration and loss of vision,” said Yang Hu, MD, PhD, associate professor of ophthalmology. “Repair genes that lead to neuroprotection and even regeneration are desperately needed.” WebbOphthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community. Ophthalmology Times - … Webbför 8 timmar sedan · Dublin, April 14, 2024 (GLOBE NEWSWIRE) -- The "United Kingdom Cell & Gene Therapy Business and Investment Opportunities Databook - Q1 2024 … 駿河屋 うさぎパンツ